Effect of aspirin on small for gestational age neonates in pregnancies at high-risk for preeclampsia: a secondary analysis of a cluster randomised clinical trial.

Additionally, aspirin administration was associated with a significant trend for a simultaneous increase in late-SGA neonates with birthweight <3rd, <5th, <10th (test for trend, P value < 0.05, Supplementary Table S1 , Fig. 1 ).

also in 6,248 other papers

1 , Table 1 ); specifically, among high-risk pregnancies with and without PE, aspirin was associated with an increasing trend in late/term-SGA neonates with birthweight <10th ( Supplementary Table S1 ); second, in the intervention phase of the trial, aspirin is associated with 61%, 62%, and 59% reduction in the incidence of early-SGA <3rd, <5th, and <10th percentile, respectively alongside a concurrent trend indicating an

also in 38,133 other papers